Skip to main content
evidena care

Interactions

Cannabis and benzodiazepines: interaction and risks

You take lorazepam, diazepam, alprazolam or clonazepam and use cannabis. What happens with the combination and what your doctor needs to know.

Key points

  • Cannabis, above all THC, and benzodiazepines both depress the central nervous system. Together, tiredness, dizziness, slowed reactions and memory gaps can be intensified.
  • CBD can slow the breakdown of individual benzodiazepines via the enzyme CYP2C19. This is well documented for clobazam; for lorazepam, diazepam, alprazolam or clonazepam there are no direct studies.
  • Older people have a higher risk of falls on benzodiazepines. Additional sedation from THC can increase this risk further.
  • Never stop a benzodiazepine abruptly, not even because of cannabis. Stopping is done only gradually and in agreement with your doctor.

Cannabis and benzodiazepines such as lorazepam (Temesta), diazepam (Valium), alprazolam (Xanax) or clonazepam (Rivotril) can be prescribed at the same time, but the combination requires a medical assessment. Both have a depressant effect on the central nervous system. Together, tiredness, drowsiness, slowed reactions and coordination problems can add up.4,9

There is also a second mechanism: CBD can slow the breakdown of some benzodiazepines in the liver. This is well documented for clobazam and only theoretically derived for the other active substances. It is therefore important that your doctor knows all your medicines and every form of cannabis or CBD. And: you never stop a benzodiazepine abruptly.1,3,6

Cannabis and benzodiazepines: what happens when they are taken together

Benzodiazepines enhance the effect of the inhibitory messenger substance GABA. They have anxiolytic, calming, sleep-promoting and muscle-relaxing effects. Via the cannabinoid receptors, THC also acts on attention, memory and movement coordination. When two substances act in the same direction, this is called a pharmacodynamic interaction: the effects can add up without the blood levels changing.9

CBD is not neutral either. In the product information of authorised CBD medicines, drowsiness and sedation are among the common side effects. A review of CBD explicitly names sedation as a side effect that can be intensified by other depressant agents.4

How strongly the effects add up varies greatly between individuals. It depends on the active substance, the dose, the time of intake, tolerance and age. Controlled studies that specifically examined THC together with lorazepam, diazepam or alprazolam are rare. The statement on additive sedation is therefore based mainly on the known pharmacology of both classes of substance.9

Respiratory depression, alcohol and other depressant agents

On their own, benzodiazepines usually depress breathing only slightly in healthy adults. The risk rises considerably when other depressant substances are added, above all alcohol, opioids, sleeping pills or certain antihistamines. According to current knowledge, cannabis alone rarely causes relevant respiratory depression, but in combination with these agents it can intensify the overall sedation. There are hardly any direct data on cannabis as a trigger of respiratory depression on benzodiazepines.4,9

People with sleep apnoea, chronic lung disease, impaired liver function or of older age should be particularly careful. Their margin is smaller. This is a reason for a thorough medical assessment, not automatically a reason to rule out treatment.6,9

CBD, CYP2C19 and clobazam: the mechanism in the liver

Many benzodiazepines are broken down in the liver via enzymes of the cytochrome P450 family. In a controlled study with 18 healthy adults, a high single oral dose of 640 mg CBD together with 20 mg THC most strongly inhibited the enzyme CYP2C19, and also CYP2C9, CYP3A and CYP1A2. THC alone in the same study showed no such inhibition.1

The best-documented example is clobazam, a benzodiazepine used in the treatment of epilepsy. In a study with 13 children with difficult-to-treat epilepsy, the level of the active metabolite N-desmethylclobazam rose on average by around 500 per cent after four weeks on CBD. In 10 of the 13 children, side effects such as tiredness occurred, which subsided after a medical reduction of the clobazam dose.2

The product information of the CBD medicine Epidyolex describes the interaction in both directions: exposure to N-desmethylclobazam rose roughly threefold in studies, probably via inhibition of CYP2C19. At the same time, an active metabolite of CBD increased. The product information states that dose adjustments may therefore be necessary.3

What this means for lorazepam, diazepam, alprazolam and clonazepam

The clobazam data cannot simply be transferred to other benzodiazepines. Diazepam is broken down via CYP2C19 and CYP3A4, among others, alprazolam and clonazepam mainly via CYP3A4. CBD-related inhibition of these enzymes could theoretically increase their levels. Lorazepam is broken down mainly by glucuronidation, that is, hardly via CYP enzymes. For all four active substances, there are no clinical studies with CBD in humans.1,9

Whether such a theoretical interaction plays a role in everyday life depends heavily on the amount of CBD. The effects shown come from studies with high CBD doses. Whether small amounts, for example from a CBD oil available without prescription, have a measurable effect is unclear. This uncertainty is a reason to declare CBD products in full.1,4

Fall risk and fitness to drive

Benzodiazepines are a known risk factor for falls in older people. In a meta-analysis of people aged 60 and over, taking benzodiazepines was associated with a risk of falls increased by around 40 per cent (odds ratio 1.42); for long-acting benzodiazepines the value was higher. Whether cannabis increases this risk further has not been specifically studied. The additional sedation and dizziness from THC make it plausible, however.5

As for driving: in a randomised study with 26 healthy occasional users, inhaled THC-containing cannabis measurably worsened lane keeping in road traffic, while CBD alone at the dose studied did not. Benzodiazepines can also impair driving performance. Legally, what counts in Switzerland is actual fitness to drive: anyone who lacks the necessary capacity because of the influence of medicines may not drive a vehicle.7,8

A valid prescription does not change this. The only thing that matters is whether you are fit to drive at the time of the journey. Therefore discuss with your doctor beforehand whether and when you can drive.8

You can read more about the legal situation when driving with a prescription in the article Driving with medical cannabis.

Dependence: why you never stop benzodiazepines abruptly

After regular use over weeks, the body can become accustomed to a benzodiazepine. Stopping suddenly without medical supervision can then trigger withdrawal symptoms: restlessness, anxiety, sleep disturbances, tremor and, in severe cases, seizures or states of confusion. A recent joint guideline from several US professional societies states that benzodiazepines should not be stopped abruptly in the case of physical dependence. Tapering should be individually planned and supervised.6

This also applies if you are newly prescribed a cannabis medicine. It is not a substitute that you can switch to on your own. Whether an existing benzodiazepine therapy is adjusted, reduced or continued is something you decide only in agreement with your doctor, ideally with the person who prescribed the benzodiazepine.6

Caution is also needed the other way round: if regular CBD use is stopped, a metabolism that was previously slowed can return to normal. With clobazam, for example, the level can then fall. Changes to CBD or cannabis therefore also belong in the conversation with your doctor.3

What you should tell your doctor

For a safe assessment, your doctor needs a complete picture. Bring this information with you:

  • which benzodiazepine you take, at what dose, how often and since when
  • whether it is taken regularly or only as needed
  • every form of cannabis or CBD, including products available without prescription and non-prescribed cannabis, with form of use and frequency
  • other depressant agents: sleeping pills, opioids, antidepressants, antihistamines, alcohol
  • falls, severe daytime tiredness or memory gaps recently
  • sleep apnoea, lung or liver disease
  • whether you drive or operate machinery

On this basis, the doctor can assess the combination, adjust timings or doses if necessary, or watch for side effects. Background on enzymes and other combinations can be found in the overview Cannabis and medicines: interactions, and on alcohol in the article Cannabis therapy and alcohol.4,9

How it works at evidena

At evidena, the doctor decides after a medical assessment whether a cannabis medicine is an option. With ongoing benzodiazepine therapy, this assessment is explicitly part of it. If a prescription is issued, it must be filled at a pharmacy within one month. The prescribed quantity normally covers one month, and at most three months of treatment in justified cases.10 You can book an appointment at https://portal.evidena.care/appointments. We answer questions via WhatsApp or at info@evidena.care. The page How it works describes how the assessment works.

Conclusion

Cannabis and benzodiazepines intensify each other’s sedating effect, with consequences for fall risk and fitness to drive. CBD can additionally slow the breakdown of individual benzodiazepines; this is well documented for clobazam. Inform your doctor fully and never change or stop a benzodiazepine on your own.

This article is for general information and does not replace individual medical advice.

Frequently asked questions

May I take cannabis and benzodiazepines at the same time?

The combination is not ruled out in principle, but it intensifies the sedating effect. Whether and how it is justifiable is decided by your doctor with knowledge of all your medicines.

Is CBD with lorazepam (Temesta) unproblematic because CBD is not intoxicating?

No, not automatically. CBD can itself cause tiredness and inhibit liver enzymes. For lorazepam, a clinically relevant CYP interaction is less likely, but the data are thin.

Can I stop my benzodiazepine when I start cannabis?

Not on your own. Stopping abruptly without a doctor can, after prolonged use, trigger withdrawal symptoms up to and including seizures. Any change is made gradually and under medical supervision.

May I drive after taking them?

Anyone who is not fit to drive because of the influence of medicines may not drive a vehicle in Switzerland. With the combination, the risk of impairment is increased; discuss driving with your doctor beforehand.

What do I do in case of severe drowsiness or breathing problems?

In case of clouded consciousness or difficulty breathing, call 144 immediately. For questions about possible poisoning, you can reach Tox Info Suisse on 145.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Bansal S et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther. 2023;114(3):693-703. doi:10.1002/cpt.2973
  2. Geffrey AL et al. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. 2015;56(8):1246-51. doi:10.1111/epi.13060
  3. Fachinformation Epidyolex 100 mg/ml (Cannabidiol), Abschnitt 4.5 «Wechselwirkungen», Clobazam und N-Desmethylclobazam. Electronic Medicines Compendium UK (accessed 11 November 2026)
  4. Brown JD et al. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. J Clin Med. 2019;8(7):989. doi:10.3390/jcm8070989
  5. Seppala LJ et al. Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-371.e17. doi:10.1016/j.jamda.2017.12.098
  6. Brunner E et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. J Gen Intern Med. 2025;40(12):2814-2859. doi:10.1007/s11606-025-09499-2
  7. Arkell TR et al. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. JAMA. 2020;324(21):2177-2186. doi:10.1001/jama.2020.21218
  8. Strassenverkehrsgesetz (SVG), SR 741.01, Art. 31, Fedlex (accessed 11 November 2026)
  9. Nachnani R et al. Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis. Front Pharmacol. 2024;15:1282831. doi:10.3389/fphar.2024.1282831
  10. Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 47, Fedlex (accessed 13 November 2026)

Written by evidena.care editorial team · Published 11 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.